Diversified Enterprises’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Diversified Enterprises’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$482K	Buy	4,066 +1	+0%	+$108	0.02%	255
2026 Q1	$422K	Buy	4,065 +2	+0%	+$211	0.02%	269
2025 Q4	$425K	Buy	4,063 +2	+0%	+$201	0.03%	237
2025 Q3	$376K	Buy	4,061 +2	+0%	+$175	0.03%	202
2025 Q2	$324K	Buy	4,059 +2	+0%	+$160	0.02%	214
2025 Q1	$351K	Buy	4,057 +2	+0%	+$170	0.03%	202
2024 Q4	$335K	Buy	4,055 +2	+0%	+$172	0.03%	170
2024 Q3	$353K	Buy	+4,053	New	+$347K	0.04%	161

Other funds holding PJP

Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $145M AUM

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

WTC

WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

SWGC

Summit Wealth Group (Colorado) Colorado Springs, Colorado $1.21B AUM 33.48% 1-Year Est. Return

Diversified Enterprises's PJP Position: Q2 2026 in Review

Diversified Enterprises increased its Invesco Pharmaceuticals ETF (PJP) stake by 0.02% in Q2 2026, buying an estimated $108 and bringing the position to 4,066 shares worth $482K. The position accounts for 0.02% of the portfolio, ranked #255.

Diversified Enterprises first reported a position in PJP in Q3 2024 and has held it in 8 quarters since. 42 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Diversified Enterprises held 4,066 shares of Invesco Pharmaceuticals ETF worth $482K as of Q2 2026.
Diversified Enterprises bought 1 Invesco Pharmaceuticals ETF share in Q2 2026, an estimated $108.
Invesco Pharmaceuticals ETF made up 0.02% of Diversified Enterprises's portfolio in Q2 2026, its #255 holding.
Diversified Enterprises first reported a position in Invesco Pharmaceuticals ETF in Q3 2024 and has held it in 8 quarters since.
42 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.